EP1056471A4 - TRAITEMENT DE LA DERMATITE ATOPIQUE A L'AIDE D'ANTAGONISTES D'IgE - Google Patents

TRAITEMENT DE LA DERMATITE ATOPIQUE A L'AIDE D'ANTAGONISTES D'IgE

Info

Publication number
EP1056471A4
EP1056471A4 EP99901309A EP99901309A EP1056471A4 EP 1056471 A4 EP1056471 A4 EP 1056471A4 EP 99901309 A EP99901309 A EP 99901309A EP 99901309 A EP99901309 A EP 99901309A EP 1056471 A4 EP1056471 A4 EP 1056471A4
Authority
EP
European Patent Office
Prior art keywords
atopic dermatitis
treating atopic
ige antagonists
ige
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99901309A
Other languages
German (de)
English (en)
Other versions
EP1056471A1 (fr
Inventor
Tse Wen Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanox Inc
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of EP1056471A1 publication Critical patent/EP1056471A1/fr
Publication of EP1056471A4 publication Critical patent/EP1056471A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99901309A 1998-01-29 1999-01-06 TRAITEMENT DE LA DERMATITE ATOPIQUE A L'AIDE D'ANTAGONISTES D'IgE Withdrawn EP1056471A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1526998A 1998-01-29 1998-01-29
US7303398P 1998-01-29 1998-01-29
US73033P 1998-01-29
US15269 1998-01-29
PCT/US1999/000135 WO1999038531A1 (fr) 1998-01-29 1999-01-06 TRAITEMENT DE LA DERMATITE ATOPIQUE A L'AIDE D'ANTAGONISTES D'IgE

Publications (2)

Publication Number Publication Date
EP1056471A1 EP1056471A1 (fr) 2000-12-06
EP1056471A4 true EP1056471A4 (fr) 2001-05-30

Family

ID=26687160

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99901309A Withdrawn EP1056471A4 (fr) 1998-01-29 1999-01-06 TRAITEMENT DE LA DERMATITE ATOPIQUE A L'AIDE D'ANTAGONISTES D'IgE

Country Status (5)

Country Link
EP (1) EP1056471A4 (fr)
JP (1) JP2002501905A (fr)
CN (1) CN1289253A (fr)
AU (1) AU2103699A (fr)
WO (1) WO1999038531A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2000481T1 (sl) * 2003-02-01 2016-08-31 Tanox, Inc. Anti-humana protitelesa IgE z visoko afiniteto
AU2008215926B2 (en) * 2007-02-15 2012-07-19 Astrazeneca Ab Binding members for IgE molecules
GB201610198D0 (en) * 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017207A1 (fr) * 1991-03-26 1992-10-15 Tanox Biosystems, Inc. ANTICORPS MONOCLONAUX QUI SE LIENT A L'IgE SECRETEE ET LIEE AUX MEMBRANES MAIS QUI NE SE LIENT PAS A L'IgE SE TROUVANT SUR LES LEUCOCYTES BASOPHILES
EP0589840A1 (fr) * 1992-09-24 1994-03-30 Ciba-Geigy Ag Anticorps monoclonaux transformés contre une isotype d'immunoglobuline
EP0648499A1 (fr) * 1993-10-19 1995-04-19 Chisei Ra Composition pour l'inhibition de la production d'IgE
EP0657534A1 (fr) * 1992-08-04 1995-06-14 The Green Cross Corporation Agent antiallergique
WO1998004718A1 (fr) * 1996-07-26 1998-02-05 Novartis Ag Polypeptides de fusion comprenant un domaine de liaison ige et un composant hsa, et leurs utilisations diagnostiques et therapeutiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017207A1 (fr) * 1991-03-26 1992-10-15 Tanox Biosystems, Inc. ANTICORPS MONOCLONAUX QUI SE LIENT A L'IgE SECRETEE ET LIEE AUX MEMBRANES MAIS QUI NE SE LIENT PAS A L'IgE SE TROUVANT SUR LES LEUCOCYTES BASOPHILES
EP0657534A1 (fr) * 1992-08-04 1995-06-14 The Green Cross Corporation Agent antiallergique
EP0589840A1 (fr) * 1992-09-24 1994-03-30 Ciba-Geigy Ag Anticorps monoclonaux transformés contre une isotype d'immunoglobuline
EP0648499A1 (fr) * 1993-10-19 1995-04-19 Chisei Ra Composition pour l'inhibition de la production d'IgE
WO1998004718A1 (fr) * 1996-07-26 1998-02-05 Novartis Ag Polypeptides de fusion comprenant un domaine de liaison ige et un composant hsa, et leurs utilisations diagnostiques et therapeutiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CORNE JONATHAN ET AL: "The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmacokinetics.", 1997, JOURNAL OF CLINICAL INVESTIGATION, VOL. 99, NR. 5, PAGE(S) 879-887, ISSN: 0021-9738, XP002164091 *
GRAHAM BROWN R. A. C. ET AL.: "Therapeutics in atopic dermatitis", 1997, ADVANCES IN DERMATOLOGY, VOL. 13, PAGE(S) 3-31, XP000983988 *
HAAK-FRENDSCHO M. ET AL.: "Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo", 1993, JOURNAL OF IMMUNOLOGY, VOL. 151, NR.1, PAGE(S) 351-358, XP000942183 *
See also references of WO9938531A1 *

Also Published As

Publication number Publication date
EP1056471A1 (fr) 2000-12-06
JP2002501905A (ja) 2002-01-22
AU2103699A (en) 1999-08-16
WO1999038531A1 (fr) 1999-08-05
CN1289253A (zh) 2001-03-28

Similar Documents

Publication Publication Date Title
IL141028A0 (en) Substituted anilide compounds and methods
PL336758A1 (en) Substituted imidazoles useful in treating inflammatory states
GB2354765B (en) Dispersion composition and method for producing the same
EP1078185A4 (fr) Soupape de regulation par zones a moteur electronique
HUP0105143A3 (en) Sandwich and method for the production thereof
GB9929174D0 (en) Boronized wear-resistant materials and methods thereof
EP1148078A4 (fr) Polyimide contenant un groupe reticulable et son procede de production
GB9909068D0 (en) Power distribution block
GB2337984B (en) Sprayer controller and method
IL138255A (en) Liquid distribution materials with improved distribution properties under sub-saturation
PL345270A1 (en) Elastane threads and method for the production thereof
GB9818255D0 (en) Threaded fastener
GB9807051D0 (en) Monitoring arrangement and method
GB0026240D0 (en) Polymers and their uses
EP1056471A4 (fr) TRAITEMENT DE LA DERMATITE ATOPIQUE A L'AIDE D'ANTAGONISTES D'IgE
GB9812519D0 (en) Treating cells
GB9821001D0 (en) Process monitoring and control methods
GB9807848D0 (en) Assay method and means
PL345074A1 (en) Thienopyridine compounds, their production and use
EP1092741A4 (fr) Polyester et procede de production de celui-ci
GB9815276D0 (en) Manufacturing method and article produced by the method
GB0108763D0 (en) Method and device for producing wear resisting surfaces
IL123118A0 (en) Threaded nut lock
TW452026U (en) Screw belt with washer
GB2342359B (en) Electrolysers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000828

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010412

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020829

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040810